As for the cholinergic transmission, it ends with the hydrolysis of the neurotransmitter acetylcholine (ACh) by either acetylcholinesterase (AChE) or butyrylcholinesterase (BuChE), two serine hydrolase enzymes which represent well‐validated targets to alleviate AD symptoms. Here, BCHE is linked to Alzheimer disease.